A $6 Billion Deal, Called Off in Silence
Bloomberg first reported on August 13, 2026 that Anthropic was in talks to buy Decart, an Israeli-founded startup, for around $6 billion. By mid-August the talks had reached an advanced stage, structured mostly as stock rather than cash. On September 8, 2026, Bloomberg reported that Anthropic had walked away after weeks of due diligence. Neither company disclosed a reason.
Decart, founded in 2023, builds chip-optimization software that makes AI inference more efficient for generative video, robotics simulation, and autonomous systems, all computationally heavy workloads. The company has raised about $450 million in total, with Nvidia among its backers. The $6 billion price Anthropic was reportedly willing to pay sat roughly 50 percent above the near-$4 billion valuation Decart's own funding round had set only in May 2026.
Why This Matters More Than the Deal Itself
The timing is the real signal. Anthropic is reportedly targeting a public listing for September or October 2026, and a $6 billion stock-based acquisition immediately beforehand would have added shareholder dilution, a more complicated financial story for new investors, and integration risk during the single most scrutinized period a company faces.
That points to something easy to miss: Anthropic is treating a clean balance sheet, right now, as more valuable than owning a compute-efficiency capability outright. Anyone assuming the frontier labs will keep buying up every promising efficiency vendor should expect the opposite around an IPO window. The largest labs pause acquisitions when they are about to be priced by public markets, which leaves independent vendors like Decart, and European challengers building similar tooling, more room to stay independent and sell to more than one customer.
What an Enterprise Buyer Should Take From This
A business leaning on an independent efficiency-tooling vendor to control its own AI infrastructure costs should not read "in acquisition talks" as imminent lock-in. Decart's founders kept roughly 64 percent ownership, real leverage to walk away from unfavorable terms, and an acquirer close to a public listing has its own reasons to avoid added complexity.
The practical lesson is to watch a lab's IPO calendar, not just the M&A rumor mill, when judging how much vendor-consolidation risk actually sits ahead.
Servola Journal
We do this for everyone trying to keep up with what technology is doing to our lives. The people who build it, and the people it happens to. The Servola Journal exists so that what we learn belongs to all of them.
Nobody pays us for this. No ads, no paywall, free to everyone. We just believe that understanding what's happening to all of us shouldn't depend on who can afford to pay for it.
If it gave you something today, tell us to keep going. Follow us, leave a like, or write a positive comment. We read every one, and they are what keeps us going.
Read next: Anthropic's Compute Bet Was Hidden Across Six Contracts | Anthropic's $30 Trillion Pitch Meets Your Contract



